If you’re of a certain generation, you’re likely to have clear memories of weekly dosings with cod liver oil (or castor oil, if you were particularly unlucky), a practice that was ostensibly a worm ...

Every week neurologist Victor Sung sees people with Huntington’s disease, a rare and devastating neurodegenerative disorder, at his clinic at the University of Alabama at Birmingham. But last ...

The U.S. Food and Drug Administration has approved a new treatment for advanced breast cancer. Drugmaker Eli Lilly announced Sept. 25 the approval of Inluriyo, an oral estrogen receptor antagonist, to ...

Histopathological image of multiple myoloma. Smear preparation of bone marrow aspirate stained with May-Grünwald-Giemsa procedure. It doest not represent a histopathologic image but essentially helps ...

Medical groups say early detection leads to better treatment outcomes. Oct.1 marks the beginning of Breast Cancer Awareness Month, and the American Cancer Society (ACS) is commemorating 40 years of ...

Zeaxanthin, best known for eye health, has been found to boost the tumor-killing power of T cells. Researchers showed it strengthens T-cell receptors, enhances immune signaling, and improves the ...

Last month, a homeless man with a history of serious mental illness killed a woman on a Charlotte train. The murder, shown on video, spurred calls from some for a tougher approach to dealing with the ...

Bryce Vissel does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond their ...

A gene therapy injected into patients’ brains slowed progression of the disease by 75 percent, preliminary findings reported. By Dana G. Smith Preliminary results from a small clinical trial to treat ...

Children have returned to school and are bringing home stories about the things they learned and the friends they made. But some parents are concerned they could also be bringing home a tiny nuisance: ...

Doctors have announced the first successful treatment for Huntington’s disease, a devastating inherited condition that combines symptoms of dementia, Parkinson’s and motor neurone disease. The ...

Leucovorin is being reviewed by the FDA for treating cerebral folate deficiency, which causes developmental delays and autism-like features in children. GSK aims to update leucovorin's label for CFD ...